We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Ingestible Scouring Sponge Identifies Esophageal Abnormities

By HospiMedica International staff writers
Posted on 12 Feb 2019
Print article
Image: An expandable polyurethane sphere helps detect esophageal cancer (Photo courtesy of CapNostics).
Image: An expandable polyurethane sphere helps detect esophageal cancer (Photo courtesy of CapNostics).
A minimally invasive esophageal cytology sampling device in the form of a small sponge can aid early diagnosis of Barrett's esophagus (BE) and esophageal cancer in high-risk patients.

The CapNostics (Doylestown, PA, USA) EsophaCap is a swallowable device made of medical grade foam compressed into an ingestible capsule that is designed for deployment within 10 minutes. Once swallowed, the gelatin coating on the capsule dissolves in under three minutes, causing the polyurethane sponge, which is attached to a string, to expand into a sphere two centimeters in diameter. The string is then gently pulled back through the mouth; as the sponge makes its way up, it collects genetic material along the length and breadth of the esophagus.

When the sponge reaches the top of the esophagus it is withdrawn, laden with DNA material that is subsequently extracted using a technique known as methylation on beads (MOB). The beads bind to the DNA, which can be easily collected and subsequently analyzed by a biomarker panel so as to identify the four methylation biomarkers that appear to best predict which patients with BE might progress to neoplasia. In a study published on January 22, 2019, in Clinical Cancer Research, EsophaCap showed a diagnostic accuracy of 86.7%, a sensitivity of 78.6%, and a specificity of 92.8% for BE detection.

“Early detection is the whole ballgame when it comes to esophageal cancer. This novel sponge device can be administered by anyone with minimal training, ideally in any physician's office, where the procedure could be routinely performed,” said senior study author Professor Stephen Meltzer, MD, of Johns Hopkins University (JHU, Baltimore, MD, USA). “This is cheaper, easier and safer than endoscopy. Nor does the EsophaCap have to be protected against contamination from DNA material as the device passes through normal esophageal tissue in smokers.”

Barrett's esophagus refers to an abnormal change (metaplasia) in the cells of the lower portion of the esophagus, when the normal squamous epithelium lining is replaced by goblet cells, which are usually found lower in the gastroitestinal tract. The medical significance of BE is its strong association with esophageal adenocarcinoma, a particularly lethal form of cancer.

Related Links:

Gold Supplier
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Ceiling-Mounted Digital X-Ray System
DigitalDiagnost C50
Ultrasound System
HERA W10 Elite
Memory Foam Mattress

Print article



view channel
Image: MyoVista Wavelet technology utilizes AI for early detection of heart disease (Photo courtesy of Heart Test Laboratories)

Novel ECG Technology Utilizes AI for Early Detection of Heart Disease

Cardiovascular disease is responsible for 17.9 million deaths every year, or about 32% of all deaths worldwide. Every week, millions of electrocardiographs (ECGs) are performed across the world, making... Read more

Surgical Techniques

view channel
Image: The Vena BDAC provides a superior solution to distal navigation (Photo courtesy of Vena Medical)

Category-Defining Balloon Distal Access Catheter Allows Surgeons to Get Much Closer to Blood Clots

Thrombectomy is a minimally invasive procedure for removing a blood clot and has now become standard of care treatment for patients with an acute ischemic stroke (AIS) secondary to a Large Vessel Occlusion (LVO).... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more


view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.